These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38369325)

  • 1. The Cornea: An Ideal Tissue for Regenerative Medicine.
    Shimmura S; Inagaki E; Hirayama M; Hatou S
    Keio J Med; 2024 Mar; 73(1):1-7. PubMed ID: 38369325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of Cellular and Tissue-based Products for Retinal Regenerative Medicine].
    Osakada F
    Yakugaku Zasshi; 2017; 137(1):23-29. PubMed ID: 28049891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in corneal regenerative medicine with iPS cells.
    Hatou S; Shimmura S
    Jpn J Ophthalmol; 2023 Sep; 67(5):541-545. PubMed ID: 37578549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pluripotent Stem Cells in Clinical Cell Transplantation: Focusing on Induced Pluripotent Stem Cell-Derived RPE Cell Therapy in Age-Related Macular Degeneration.
    Yang YP; Hsiao YJ; Chang KJ; Foustine S; Ko YL; Tsai YC; Tai HY; Ko YC; Chiou SH; Lin TC; Chen SJ; Chien Y; Hwang DK
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous Induced Pluripotent Stem Cell-Based Cell Therapies: Promise, Progress, and Challenges.
    Madrid M; Sumen C; Aivio S; Saklayen N
    Curr Protoc; 2021 Mar; 1(3):e88. PubMed ID: 33725407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status and perspectives on stem cell-based therapies undergoing clinical trials for regenerative medicine: case studies.
    Ratcliffe E; Glen KE; Naing MW; Williams DJ
    Br Med Bull; 2013; 108():73-94. PubMed ID: 24200742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human iPSC banking: barriers and opportunities.
    Huang CY; Liu CL; Ting CY; Chiu YT; Cheng YC; Nicholson MW; Hsieh PCH
    J Biomed Sci; 2019 Oct; 26(1):87. PubMed ID: 31660969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Status and prospects for the development of regenerative therapies for corneal and ocular diseases.
    Takayanagi H; Hayashi R
    Regen Ther; 2024 Jun; 26():819-825. PubMed ID: 39329098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards Personalized Regenerative Cell Therapy: Mesenchymal Stem Cells Derived from Human Induced Pluripotent Stem Cells.
    Lin L; Bolund L; Luo Y
    Curr Stem Cell Res Ther; 2016; 11(2):122-30. PubMed ID: 26201862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induced Pluripotent Stem Cell-Derived Corneal Cells: Current Status and Application.
    Mahmood N; Suh TC; Ali KM; Sefat E; Jahan UM; Huang Y; Gilger BC; Gluck JM
    Stem Cell Rev Rep; 2022 Dec; 18(8):2817-2832. PubMed ID: 35913555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced pluripotent stem cells and their implication for regenerative medicine.
    Csobonyeiova M; Polak S; Koller J; Danisovic L
    Cell Tissue Bank; 2015 Jun; 16(2):171-80. PubMed ID: 25037593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced pluripotent stem cells (iPSC)-derived retinal cells in disease modeling and regenerative medicine.
    Rathod R; Surendran H; Battu R; Desai J; Pal R
    J Chem Neuroanat; 2019 Jan; 95():81-88. PubMed ID: 29448001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal and Induced Pluripotent Stem Cells-Derived Extracellular Vesicles: The New Frontier for Regenerative Medicine?
    Barreca MM; Cancemi P; Geraci F
    Cells; 2020 May; 9(5):. PubMed ID: 32397132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replacing what's lost: a new era of stem cell therapy for Parkinson's disease.
    Fan Y; Winanto ; Ng SY
    Transl Neurodegener; 2020; 9():2. PubMed ID: 31911835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large Animal Models for the Clinical Application of Human Induced Pluripotent Stem Cells.
    Cong X; Zhang SM; Ellis MW; Luo J
    Stem Cells Dev; 2019 Oct; 28(19):1288-1298. PubMed ID: 31359827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced Pluripotent Stem Cell Therapies for Degenerative Disease of the Outer Retina: Disease Modeling and Cell Replacement.
    Di Foggia V; Makwana P; Ali RR; Sowden JC
    J Ocul Pharmacol Ther; 2016 Jun; 32(5):240-52. PubMed ID: 27027805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personalized Regenerative Medicine.
    Arjmand B; Goodarzi P; Mohamadi-Jahani F; Falahzadeh K; Larijani B
    Acta Med Iran; 2017 Mar; 55(3):144-149. PubMed ID: 28282715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induced pluripotent stem cell-derived extracellular vesicles: A novel approach for cell-free regenerative medicine.
    Taheri B; Soleimani M; Fekri Aval S; Esmaeili E; Bazi Z; Zarghami N
    J Cell Physiol; 2019 Jun; 234(6):8455-8464. PubMed ID: 30478831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical applications of pluripotent stem cells and their derivatives: current status and future perspectives.
    Pendse S; Vaidya A; Kale V
    Regen Med; 2022 Sep; 17(9):677-690. PubMed ID: 35703035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corneal Endothelial-like Cells Derived from Induced Pluripotent Stem Cells for Cell Therapy.
    Ng XY; Peh GSL; Yam GH; Tay HG; Mehta JS
    Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.